Silent hypoxia in patients with SARS CoV-2 infection before hospital discharge
- PMID: 32663601
- PMCID: PMC7836996
- DOI: 10.1016/j.ijid.2020.07.014
Silent hypoxia in patients with SARS CoV-2 infection before hospital discharge
Abstract
Objective: To assess the degree of hypoxia and subjective dyspnea elicited by a 6-minute walking test (6MWT) in COVID-19 patients prior to discharge.
Methods: A 6MWT was performed in 26 discharge-ready COVID-19 patients without chronic pulmonary disease or cardiac failure. Heart rate, oxyhemoglobin saturation (SpO2), respiratory rate, and subjective dyspnea measured on the Borg CR-10 scale were measured before and immediately after the 6MWT, with continuous monitoring of SpO2 and heart rate during the 6MWT. The 6MWT was terminated if SpO2 dropped below 90%. A historical cohort of 204 patients with idiopathic pulmonary fibrosis (IPF) was used for comparison.
Results: 13 (50%) of the COVID-19 patients developed exercise-induced hypoxia (SpO2 < 90%) during the 6MWT, of which one third had pulmonary embolism. COVID-19 patients experienced less hypoxia-related dyspnea during the 6MWT compared with patients with IPF.
Conclusion: The 6MWT is a potential tool in the diagnosis of asymptomatic exercise-induced hypoxia in hospitalized COVID-19 patients prior to discharge. Due to important methodological limitations, further studies are needed to confirm our findings and to investigate their clinical consequences.
Keywords: COVID-19; Discharge; Dyspnea; Exercise test; Hypoxia.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.
Figures
References
-
- Borg G.A. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14(5):377–381. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous
